Gene-Edited Pig Kidney Functions Successfully in Macaque for Over a Year, Marking Xenotransplantation Milestone
Table of Contents
A groundbreaking achievement in xenotransplantation has been reported by Chinese scientists, demonstrating the successful function of a gene-edited pig kidney in a macaque monkey for more than one year. The development signals a major step forward in addressing the global organ shortage and positions China at the forefront of this pioneering field.
Researchers from a hospital affiliated with Tongji Medical College at the Huazhong University of Science and Technology announced the results on Thursday. The experiment, led by professor Chen Gang from the hospital’s institute of organ transplantation, provides a robust scientific foundation for future clinical trials.
Advancing the Field of Xenotransplantation
This breakthrough comes as part of a global effort to overcome the critical shortage of human organs for transplant. Approximately 2 million people worldwide are in need of an organ each year, yet fewer than 10% receive one. Xenotransplantation – the process of transplanting living cells, tissues or organs from one species to another – offers a potential solution, with pigs considered ideal donors due to their physiological similarities to humans and the relative ease of genetic modification.
Prior research teams in the United States have also achieved success in sustaining organ survival in primates using gene-edited donor pigs for over a year, highlighting the international momentum in this area. A member of the Chinese Society of Organ Transplantation noted that this latest development firmly establishes China as a leader in the field.
Overcoming Key Obstacles to Cross-Species Transplants
The primary hurdle in xenotransplantation remains the challenge of immune rejection. The body’s natural defenses recognize animal organs as foreign and launch an attack, leading to organ failure. Chen’s team, which conducted China’s earliest animal xenotransplantation experiment in 1999, has focused on overcoming this obstacle for decades.
Two key challenges were addressed in this latest study. First, the team tackled the issue of porcine cytomegalovirus, a common virus in gene-edited pigs that can trigger rejection. They sourced specific pathogen-free “clean pigs” to eliminate the virus at its source. Second, they developed a comprehensive drug protocol for precise immunosuppression, allowing for careful dosage adjustments to prevent rejection without increasing the risk of dangerous infections.
“For end-stage patients when no organs are available, xenotransplantation is a beacon of hope for life extension,” Chen said.
This success represents a significant leap toward making xenotransplantation a viable option for patients in need, offering a potential lifeline for those awaiting a life-saving organ transplant.
